Gene Therapy Pioneers Discuss What's Next for Gene Therapy

3:00 PM - 4:00 PM (PDT), Wednesday, June 15, 2022 ・ Upper Level, Session Room 2

Recent successes in genetic medicine (regulatory approvals of Zolgensma and Luxturna, for example) have paved the path for a broader second wave of therapies and laid the foundation for next-generation technologies. But there are still obstacles for these therapies, for example safety signals, expression in target tissues, and longevity of effect. From the expert panel of gene therapy pioneers, we will hear about some of the challenges and how they are being tackled.

Dr. Goldsmith, CEO of a leading genetic medicines company, will moderate the interactive panel discussion. He will pose questions to get at how gene therapy will likely reshape the future of biomedical research and medicine.

Discussion topics likely will include: 
- Immune response to gene delivery vectors and products of foreign transgenes
- Gene-editing technologies
- The future of functional genomics, given that only approximately 6,000 of approx. 20,000 human genes are known

Passage Bio
Full Professor of Biochemistry and Molecular Biology and Director of the Center of Animal Biotechnology and Gene Therapy at the Universitat Autònoma Barcelona
Universitat Autònoma Barcelona
University of California, Los Angeles
Director, Gene Therapy Program, University of Pennsylvania
Gene Therapy Program at the University of Pennsylvania